Immune escape mechanisms and therapeutic advances in virus-associated hematological malignancies - Top-Institutions - MDSpire

Immune escape mechanisms and therapeutic advances in virus-associated hematological malignancies

  • By

  • Tingting Li

  • Chaoyu Wang

  • Qing Xiao

  • Xiaomei Zhang

  • Zailin Yang

  • Jun Li

  • Yao Liu

  • February 25, 2026

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    National Cancer Institute (NCI), NIH
    National Cancer Institute (NCI), NIH

    Bethesda, MD

    Key Differentiators

    • Hematology
    • Oncology
    • Virology
    • Immunotherapy

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology
    • Oncology
    • Immunotherapy

  • #3

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Immunotherapy
    • Virology

  • #4

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology
    • Immunotherapy

  • #5

    University of Pennsylvania (Perelman School of Medicine)
    University of Pennsylvania (Perelman School of Medicine)

    Philadelphia, PA

    Key Differentiators

    • Hematology
    • Immunotherapy
    • Virology

Original Source(s)

Immune escape mechanisms and therapeutic advances in virus-associated hematological malignancies

  • by Tingting Li, Chaoyu Wang, Qing Xiao, Xiaomei Zhang, Zailin Yang, Jun Li, Yao Liu

  • February 25, 2026

Related Content

Dana-Farber Cancer Institute and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center recognized for exceptional outcomes in donor stem cell transplants

Dana-Farber Cancer Institute’s adult stem cell transplant program and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center’s pediatric stem cell transplant program have once again received exceptional ratings from the Center for International Blood & Marrow Transplant Research (CIBMTR), earning a +1 performance score, the highest possible designation, on their annual center-specific survival reports.

  • by

  • December 17, 2025

  • 4 min
Delays in Hematology Consultations and Non-Hematology Referrals in Blood Cancer Diagnosis: Insights from a Comprehensive National Survey in Australia

Mechanisms of first-line treatment resistance in diffuse large B-cell lymphoma